Valora (VALN SW) – FY sales 2.86bn (vs cons 2.86bn) / EBIT 82m (vs cons 84.8m) / net profit 66.5m (vs cons 56.7m) Outlook: company targets 4bn sales by 2012 – will sell its own brands production unit (BB).

Publigroup (PUBN SW) – FY sales 2.084bn (vs cons 2.102bn) / EBIT 61.8m (vs cons 69.1m) / net profit 53.9m (vs cons 52.8m) Outlook: says a favorable advertising environment should make for an improvement of the group’s operating performance in 2007 (BB).

Roche (ROG VX) – Canadian authorities issue order to post warning label on Tamiflu relating to abnormal behaviour in Japanese kids (BB). 

Genentech will invest USD 140m in a drug manufacturing facility in Singapore to produce Lucentis (age related eye disease) (BB).

Nestle (NESN VX) – said it had reached a final agreement with Coca Cola over the refocusing of their Beverage Partners Worldwide tea Joint venture (BB).

ZurichFin (ZURN VX) – Investor Day today (BB).

Unilabs (ULB SW) – CEO Zwirn in Handelszeitung saying that while he would like to remain independent he is aware that Australia’s Sonic Healthcare is interested in taking out Unilabs – price of CHF 50 has been mentioned in the market but no official bid – Zwirn say would reject a CHF 50 offer in any case as too low (Handelszeitung).

Givaudan (GIVN VX) – announces joint-venture with ChemCom on smell research (BB).

Oerlikon (OERL XV) – According to Georg Stumpf company wants to grow further – 5-10bn available – rumours named Sulzer, Schweiter and Ascom (BB).